We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Restructure Would Give EMA Four New Drug-Support Divisions
Restructure Would Give EMA Four New Drug-Support Divisions
October 8, 2013
Initial plans for restructuring the European Medicines Agency, released Sept. 16, call for the creation of four new drug oversight divisions and new structures to support the scientific work of the agency’s committees.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor